HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 63,300
+600 (0.96%)
At close: Apr 9, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 451.1 billion as of April 10, 2026. Its market cap has increased by 188.62% in one year.
Market Cap
451.10B
Enterprise Value
456.80B
Revenue
12.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
63,300.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 451.10B, an increase of 295.09%. That is a compound annual growth rate of 161.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 451.10B | 37.74% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.08T |
| Myung In Pharmaceutical LTD. | 821.98B |
| Samyang Biopharm | 576.28B |
| ImmuneOncia Therapeutics | 540.63B |
| CellBion | 365.70B |
| GREEN CROSS WellBeing | 247.01B |
| DAE HWA Pharmaceutical | 244.01B |
| NOVAREX | 233.67B |